# Central Pacific Financial Corp: financial statements, quarterly

CPF · NYSE · CIK 701347 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cpf.md) · [Financials](/companies/cpf/financials.md) · [Filings](/companies/cpf/filings.md) · [Insiders](/companies/cpf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cpf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.0](/filings/0000701347-24-000039.md) | [15.2 d](/filings/0000701347-26-000021.md) | [11.2](/filings/0000701347-25-000017.md) | [12.1](/filings/0000701347-25-000027.md) | [12.7](/filings/0000701347-25-000049.md) | [2.6 d](/filings/0000701347-26-000021.md) | [11.1](/filings/0000701347-26-000028.md) | [13.0](/filings/0000701347-26-000068.md) | [13.5](/filings/0000701347-25-000049.md) | [14.2 d](/filings/0000701347-26-000021.md) | [11.6](/filings/0000701347-26-000028.md) | [14.6](/filings/0000701347-26-000068.md) |
| Interest expense | $m | [20.5](/filings/0000701347-24-000039.md) | [23.0 d](/filings/0000701347-24-000006.md) | [24.2](/filings/0000701347-24-000016.md) | [23.9](/filings/0000701347-24-000029.md) | [24.0](/filings/0000701347-24-000039.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.3](/filings/0000701347-24-000039.md) | [4.3 d](/filings/0000701347-26-000021.md) | [4.0](/filings/0000701347-25-000017.md) | [4.8](/filings/0000701347-25-000027.md) | [3.8](/filings/0000701347-25-000049.md) | [2.1 d](/filings/0000701347-26-000021.md) | [4.8](/filings/0000701347-26-000028.md) | [5.6](/filings/0000701347-26-000068.md) | [5.1](/filings/0000701347-25-000049.md) | [5.3 d](/filings/0000701347-26-000021.md) | [6.2](/filings/0000701347-26-000028.md) | [6.1](/filings/0000701347-26-000068.md) |
| Net income | $m | [13.1](/filings/0000701347-24-000039.md) | [14.9 d](/filings/0000701347-26-000021.md) | [12.9](/filings/0000701347-25-000049.md) | [15.8](/filings/0000701347-25-000049.md) | [13.3](/filings/0000701347-25-000049.md) | [11.3 d](/filings/0000701347-26-000021.md) | [17.8](/filings/0000701347-26-000028.md) | [18.3](/filings/0000701347-26-000068.md) | [18.6](/filings/0000701347-25-000049.md) | [22.9 d](/filings/0000701347-26-000021.md) | [20.7](/filings/0000701347-26-000028.md) | [20.8](/filings/0000701347-26-000068.md) |
| Diluted EPS | $ per share | [0.49](/filings/0000701347-24-000039.md) | not reported | [0.48](/filings/0000701347-25-000017.md) | [0.58](/filings/0000701347-25-000027.md) | [0.49](/filings/0000701347-25-000049.md) | not reported | [0.65](/filings/0000701347-26-000028.md) | [0.67](/filings/0000701347-26-000068.md) | [0.69](/filings/0000701347-25-000049.md) | not reported | [0.78](/filings/0000701347-26-000028.md) | [0.80](/filings/0000701347-26-000068.md) |
| Basic EPS | $ per share | [0.49](/filings/0000701347-24-000039.md) | not reported | [0.48](/filings/0000701347-25-000017.md) | [0.58](/filings/0000701347-25-000027.md) | [0.49](/filings/0000701347-25-000049.md) | not reported | [0.66](/filings/0000701347-26-000028.md) | [0.68](/filings/0000701347-26-000068.md) | [0.69](/filings/0000701347-25-000049.md) | not reported | [0.79](/filings/0000701347-26-000028.md) | [0.80](/filings/0000701347-26-000068.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [7,638](/filings/0000701347-23-000041.md) | [7,643](/filings/0000701347-25-000007.md) | [7,410](/filings/0000701347-24-000016.md) | [7,387](/filings/0000701347-24-000029.md) | [7,415](/filings/0000701347-24-000039.md) | [7,472](/filings/0000701347-26-000021.md) | [7,405](/filings/0000701347-25-000017.md) | [7,370](/filings/0000701347-25-000027.md) | [7,421](/filings/0000701347-25-000049.md) | [7,409](/filings/0000701347-26-000068.md) | [7,495](/filings/0000701347-26-000028.md) | [7,501](/filings/0000701347-26-000068.md) |
| Total liabilities | $m | [7,169](/filings/0000701347-23-000041.md) | [7,139](/filings/0000701347-25-000007.md) | [6,903](/filings/0000701347-24-000016.md) | [6,868](/filings/0000701347-24-000029.md) | [6,872](/filings/0000701347-24-000039.md) | [6,934](/filings/0000701347-26-000021.md) | [6,848](/filings/0000701347-25-000017.md) | [6,801](/filings/0000701347-25-000027.md) | [6,833](/filings/0000701347-25-000049.md) | [6,817](/filings/0000701347-26-000068.md) | [6,901](/filings/0000701347-26-000028.md) | [6,905](/filings/0000701347-26-000068.md) |
| Long-term debt | $m | [156](/filings/0000701347-23-000041.md) | [156](/filings/0000701347-25-000007.md) | [156](/filings/0000701347-24-000016.md) | [156](/filings/0000701347-24-000029.md) | [156](/filings/0000701347-24-000039.md) | [156](/filings/0000701347-26-000021.md) | [131](/filings/0000701347-25-000017.md) | [131](/filings/0000701347-25-000027.md) | [132](/filings/0000701347-25-000049.md) | [76.5](/filings/0000701347-26-000068.md) | [76.5](/filings/0000701347-26-000028.md) | [76.5](/filings/0000701347-26-000068.md) |
| Short-term borrowings | $m | [0.0](/filings/0000701347-23-000041.md) | [0.0](/filings/0000701347-26-000021.md) | not reported | not reported | not reported | [0.0](/filings/0000701347-26-000021.md) | not reported | not reported | not reported | [0.0](/filings/0000701347-26-000021.md) | not reported | not reported |
| Shareholders' equity | $m | [469](/filings/0000701347-24-000039.md) | [504](/filings/0000701347-26-000021.md) | [507](/filings/0000701347-25-000049.md) | [519](/filings/0000701347-25-000049.md) | [544](/filings/0000701347-25-000049.md) | [538](/filings/0000701347-26-000068.md) | [557](/filings/0000701347-26-000068.md) | [569](/filings/0000701347-26-000068.md) | [588](/filings/0000701347-25-000049.md) | [593](/filings/0000701347-26-000068.md) | [594](/filings/0000701347-26-000068.md) | [596](/filings/0000701347-26-000068.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.2 d](/filings/0000701347-24-000039.md) | [21.6 d](/filings/0000701347-26-000021.md) | [17.0](/filings/0000701347-25-000017.md) | [26.0 d](/filings/0000701347-25-000027.md) | [21.3 d](/filings/0000701347-25-000049.md) | [26.3 d](/filings/0000701347-26-000021.md) | [20.4](/filings/0000701347-26-000028.md) | [35.1 d](/filings/0000701347-26-000068.md) | [21.4 d](/filings/0000701347-25-000049.md) | [20.5 d](/filings/0000701347-26-000021.md) | [18.3](/filings/0000701347-26-000028.md) | [42.9 d](/filings/0000701347-26-000068.md) |
| Capital expenditure | $m | [2.7 d](/filings/0000701347-24-000039.md) | [1.7 d](/filings/0000701347-26-000021.md) | [3.3](/filings/0000701347-25-000017.md) | [4.7 d](/filings/0000701347-25-000027.md) | [5.6 d](/filings/0000701347-25-000049.md) | [1.5 d](/filings/0000701347-26-000021.md) | [0.9](/filings/0000701347-26-000028.md) | [2.0 d](/filings/0000701347-26-000068.md) | [0.9 d](/filings/0000701347-25-000049.md) | [1.4 d](/filings/0000701347-26-000021.md) | [1.1](/filings/0000701347-26-000028.md) | [1.9 d](/filings/0000701347-26-000068.md) |
| Dividends paid | $m | [7.0 d](/filings/0000701347-24-000039.md) | [7.0 d](/filings/0000701347-26-000021.md) | [7.0](/filings/0000701347-25-000017.md) | [7.0 d](/filings/0000701347-25-000027.md) | [7.0 d](/filings/0000701347-25-000049.md) | [7.0 d](/filings/0000701347-26-000021.md) | [7.3](/filings/0000701347-26-000028.md) | [7.3 d](/filings/0000701347-26-000068.md) | [7.3 d](/filings/0000701347-25-000049.md) | [7.5 d](/filings/0000701347-26-000021.md) | [7.6](/filings/0000701347-26-000028.md) | [7.5 d](/filings/0000701347-26-000068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.5](/filings/0000701347-23-000041.md) | [27.1](/filings/0000701347-24-000016.md) | [27.1](/filings/0000701347-24-000029.md) | [27.1](/filings/0000701347-24-000039.md) | [27.1](/filings/0000701347-25-000017.md) | [27.1](/filings/0000701347-25-000027.md) | [27.2](/filings/0000701347-25-000049.md) | [27.2](/filings/0000701347-26-000028.md) | [27.1](/filings/0000701347-26-000068.md) | [27.1](/filings/0000701347-25-000049.md) | [26.4](/filings/0000701347-26-000028.md) | [26.1](/filings/0000701347-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,747,432 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000701347-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.